Trial Profile
A Phase III Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Multi-Centre Study to Evaluate the Safety and Efficacy of Infliximab in Combination With Methotrexate for the Long-term Treatment of Crohn's Disease (CD)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2013
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Methotrexate (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms COMMIT
- 05 Nov 2010 New trial record.